Institutional investors purchased a net $7.5 million shares of AZN during the quarter ended September 2013, and now own 10.67% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ROBECO INVESTMENT MANAGEMENT, IN... Bought 2.5 Million shares of AstraZeneca PLC
WELLINGTON MANAGEMENT CO. LLP Bought 1.8 Million shares of AstraZeneca PLC
PUTNAM INVESTMENT MANAGEMENT LLC Bought 1.7 Million shares of AstraZeneca PLC